|

Use of an Intrauterine Manipulator and Its Correlation with Positive Peritoneal Cytology in Early Stage Endometrial Cancers

RECRUITINGN/ASponsored by WellSpan Health
Actively Recruiting
PhaseN/A
SponsorWellSpan Health
Started2020-10-15
Est. completion2026-04-30
Eligibility
Age18 Years+
SexFEMALE
Healthy vol.Accepted
Locations1 site

Summary

This study aims to answer whether use of a Vcare® intrauterine manipulator leads to an increased incidence of positive peritoneal cytology in patients undergoing surgical management of early stage (FIGO stage I/II) endometrial cancer.

Eligibility

Age: 18 Years+Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Subjects age 18 or older able to give informed consent
* Biopsy diagnosed endometrial cancer (including endometrioid, serous, mucinous and clear cell histologies)
* Planned standard of care surgical management of early stage endometrial cancer
* No clinical evidence of disseminated intraperitoneal disease

Exclusion Criteria:

* Final pathology does not reflect diagnosis of endometrial cancer (including endometrioid, serous, mucinous, and clear cell histology)
* Evidence of disseminated intraperitoneal disease
* Subject is not a surgical candidate
* Subject elects for fertility sparing or non-operative management
* Subject is unable to provide informed consent

Conditions2

CancerEndometrial Cancer

Locations1 site

Wellspan Health
York, Pennsylvania, 17403
Graham Brown, DO717-851-6120gbrown5@wellspan.org

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.